Readings for 10/22/19

Three Interesting Things:
1.) I think it is interesting that samples were even allowed in the beginning. Once a drug is taken to market there has been so much research done to prove that this drug is safe and effective. Why would the manufacturing company want to risk the work they did in a clinical trial by distributing samples with improper instructions on how to store or package the drug.
2.) I find it interesting the drugs cannot be imported into the country due the fact that the FDA has not regulated them on safety and efficacy. This makes me understand more how individuals with certain conditions seek treatment in other countries because those therapies cannot be done in the US based on regulatory grounds. Unless they are imported in small doses and for serious conditions, they cannot be used in the US. I guess this could stop patients fro importing drugs not yet regulated and then reselling them to others for profit.
3.) I think it is interesting how the E-Sign has caused such controversy. Specifically, how the act of using paper document for prescriptions might be void because the electronic signature would override it. If someone trued to use the paper signature over the E-sign or the E-sign over the paper prescription, then they would be null and void; it has to be one or the other.

Three Questions:
1.) If state regulation must not impede on federal regulation of drugs then why is marijuana handled desperately? How come in the case of the Californian terminally ill resident, the DEA said it was legal in California but not federally so they destroyed the plants rather than prosecuting?
2.) Would wholesaling drugs be a form of a grey market channel or a black market?
3.) Why would Plan B be instituted as a prescription only drug if it showed no abuse and minimal physical/mental harms?

Comments

Post a Comment

Popular posts from this blog

Readings for 11/21

Three Interesting Things: 1.) I think it is interesting that some patients avoid treating their pain with opioids because of the negative connotation given by the media surrounding these drugs. Although, yes, they can be addictive there are ways to manage the intake so that you can both treat your pain and not become addicted. 2.) I think that the fact that patients could have to sign a narcotic contract to ensure that they will not go to fill the prescription at another pharmacy. I think that this is an excessive way to do this but I also feel that this is the only way to keep patients honest because of people within these situations these people cannot control their need. 3.) I think that it is interesting that this article brings up the topic of having pharmacists be more intuned with their work and be more educating for their patients. We have talked about often how pharmacists should have more of a comforting position with their patients and be able to have empathy for them. ...
Read more

Reading for 9/24

Three Interesting Things: 1.) I had no idea that the term "Clinical Research" only applied to studies and trials done on humans rather then animals or other test subjects. When grouping them all together you tend to have a broader or less abstract view of what the study actually entails but breaking down the term makes you start to separate the trial in your mind ahead of time. 2.) I think it is interesting that the FDA approves and regulates drug advertising but yet some companies still get away with falsifying their information about a drug when advertising it. There have been a multitude of law suits where patients experience a side affect or undesired outcome due to advertisements lacking certain information. With the most regulatory group approving all of this it is funky that some still slip through the cracks. 3.) I think that when it comes to naming drugs there is a laboratory name and then a manufacturing name. Its basically further splitting up the industry in...
Read more

Reflection 10/27

This week we learned about Federal Regulation with Dr. Baker. When it comes to regulation there is much to take in because there are many boxes to check state and federal wise. The US is one of the most efficient countries when it comes to regulating the drugs brought to market. The reason for doing so is because with healthcare resources being so scarce, there is no room for medical errors. This means that the regulatory committees want to get drugs to patients that are safe and effective that will not cause controversy in the future. The FDA's job is to decide what is actually considered a drug, whether this drug is going to need a prescription or can be over the counter, double check marketing efforts of the drug, and then finally make sure that all drugs that need proper FDA documentation have it. To those trying to experiment with drugs, they may see this process to be over bearing but it is specifically put in place to make sure that patients are receiving proper care. The ov...
Read more